Trial Profile
A Randomized, Double-Blind, Multi-Center, Parallel-Group Study of Tapentadol Immediate Release (IR) Versus Oxycodone IR for the Treatment of Subjects With Acute Post-Operative Pain Following Elective Arthroscopic Shoulder Surgery.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Nov 2012
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary) ; Oxycodone
- Indications Postoperative pain
- Focus Therapeutic Use
- 09 Jan 2012 Actual initiation date changed from Jan 2009 to Dec 2008 as reported by ClinicalTrials.gov.
- 23 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2010 Planned end date changed from Jan 2010 to Mar 2010 as reported by ClinicalTrials.gov.